Repair and Recovery: From Patient Profile to Protocol
This session moves from mechanism to prescription — walking through how BPC-157, TB-500, and KPV can be sequenced and adjusted over time.
Join Laura Young, FDN-P, HHP, AADP, peptide education specialist*, for another practical, evidence-informed session focused on protocol design. Rather than reviewing peptides in isolation, this session works through three complete patient profiles to show how protocols are actually built, sequenced, and adjusted over time.
What you’ll walk away with
- Three complete protocols: the aging lifter, the unresolved chronic injury, and the surgical patient.
- Why KPV goes first — the two-week lead-in that changes how the rest of the stack performs.
- Surgical timing considerations — from injury onset through the pre-op window, the resume window, and which oral formulations continue uninterrupted.
- Tiered dosing frameworks across optimization and severe-injury cases.
- Guidance on which markers to monitor for mechanism and safety.
- A week-by-week framework for setting patient expectations and supporting protocol adherence.
- February 2027 PCAC review — GHK-Cu, PEG-MGF, and what a recommendation does and doesn’t mean.
Who should attend
Physicians, nurse practitioners, physician assistants, and other licensed prescribers; peptide clinic owners and operators; telehealth platform leaders and clinical teams; and anyone building or scaling a practice model that includes preventive care, metabolic health, hormone optimization, or longevity medicine.
45 minutes, followed by live Q&A.
*The presenter is an independent consulting expert speaking solely in their individual professional capacity and does not represent the policies, guidance, or clinical standards of MediVera Compounding Pharmacy™ or any affiliated professional practices. Content reflects the presenter’s independent professional judgment and is not intended to establish, modify, or substitute for the clinical judgment of any licensed provider.
Compounded medications referenced are not reviewed by the FDA for safety or effectiveness and are prepared by prescription for individual patients. Providers are solely responsible for determining their appropriateness.
